Updates in HER2 Testing in Breast Cancer

Course overview

This one-hour interactive, online CME/CMLE module is designed to help pathologists and laboratory professionals review and apply key concepts from the ASCO/CAP 2018 focused update on HER2 testing. The module will include a review of the ASCO/CAP 2018 focused update in HER2 testing in breast cancer, as well as application of the updates through case-based scenarios. Course Outline: * Overview of HER2 testing * HER2 analysis by immunohistochemistry * HER2 analysis by FISH * HER2 analysis by CISH * Two interactive cases on invasive micropapillary carcinoma and invasive lobular carcinoma Learning Objective: Upon completion of this activity, you should be able to: * Apply key concepts from the ASCO/CAP 2018 focused update on HER2 testing in breast cancer Faculty: Aysegul A Sahin, MD Professor, Department of Pathology, Division of Pathology/Lab Medicine Section Chief of the Breast Pathology Section, Department of Pathology, Division of Pathology/Lab Medicine Director of Educational Operations, Department of Pathology, Division of Pathology/Lab Medicine The University of Texas MD Anderson Cancer Center Houston, TX Ali Brown, MD, FASCP Chief Officer, Medical Quality American Society for Clinical Pathology Washington, DC Erin Downs-Kelly, DO Director, Breast Pathology, Cleveland Clinic Cleveland, OH Shi Wei, MD Professor, Department of Pathology, Division of Pathology/Lab Medicine Head of Surgical Pathology Section, Division of Anatomic Pathology, Department of Pathology Director of Surgical Pathology Fellowship Program The University of Alabama at Birmingham Birmingham, AL